AccessClosure Launches Mynx Ace Vascular Closure Device

March 29, 2014—AccessClosure Inc. (Santa Clara, CA) announced the commercial launch of its Mynx Ace vascular closure device at ACC.14: the 63rd annual scientific session of the American College of Cardiology being held March 29–31, in Washington, DC.

According to AccessClosure, the Mynx Ace is a safe and secure vascular closure device that provides consistent results with a new, easy-to-use deployment system to seal femoral artery access sites. Mynx Ace can be used with patients who have undergone diagnostic or interventional endovascular procedures utilizing a 5-F, 6-F, or 7-F procedural sheath.

The company noted that its family of Mynx closure devices is designed for patient comfort by providing gentle vascular closure without the use of cinching, sutures, or metal implants. The Mynx Ace allows for consistent closure of femoral artery access sites through a simple, three-step deployment system. The Mynx Ace system uses AccessClosure’s Grip technology, which employs an extravascular sealant that actively adheres to the artery for safe and secure mechanical closure and dissolves within 30 days.

“After completing over 50 cases with Mynx Ace, I have found the system provides consistent results while offering the safety, security and patient-friendly advancements I have come to trust in Mynx products,” commented Rajesh Dave, MD, in the company’s press release. Dr. Dave, who is a cardiologist from Holy Spirit Hospital in Camp Hill, Pennsylvania, added, “The advancements have made Mynx Ace a preferred closure device in my practice.”